Science Current Events | Science News | Brightsurf.com
 

FDA panel approves memantine for moderate to severe Alzheimer's: NMDA receptor antagonist.(Rx): An article from: Internal Medicine News


by Elizabeth Mechcatie

List Price: $5.95
Available: Available for download now
Studio: International Medical News Group
Binding: Digital
Number Of Pages: 2
Publication Date: November 01, 2003
Publisher: International Medical News Group


FORMATS

  • HTML


EDITORIAL REVIEWS

Product Description
This digital document is an article from Internal Medicine News, published by International Medical News Group on November 1, 2003. The length of the article is 578 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: FDA panel approves memantine for moderate to severe Alzheimer's: NMDA receptor antagonist.(Rx)
Author: Elizabeth Mechcatie
Publication: Internal Medicine News (Magazine/Journal)
Date: November 1, 2003
Publisher: International Medical News Group
Volume: 36 Issue: 21 Page: 27(1)

Distributed by Thomson Gale
© 2008 BrightSurf.com